Supernus Pharmaceuticals (SUPN) Q4 2020 Earnings

3NovConfirmed
Q1 2020
Q2 2020
Aug 20
Q4 2020
0.27
0.43
0.58
0.74

Details

Expected EPS
0.32
Actual EPS
0.74
Surprise EPS
0.42
Surprise Percent
+131.25%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.74 per share for Q4 2020.

0 Comments

Share your thoughts